LGALS3BP and Alzheimer disease: After extensive meta-analysis, we only found alterations at mRNA level for AZGBP1 and ALPP in Parkinson’s disease [47], and LGALS3BP in Lewy body dementia [48]; and thus, suggesting that the deregulated proteins identified in our study were mostly specific of AD.